参考文献/References:
[1] Dela Morena-Barrio B,Stephens J,Dela Morena-Barrio ME,et al.Long-read sequencing identifies the first retrotransposon insertion and resolves structural variants causing antithrombin deficiency[J].Thromb Haemostasis,2022,122(8):1369-1378.
[2] 闵 琦,刘 剑.不同分度脾脏破裂行全脾切除术后患者凝血功能变化临床研究[J].陕西医学杂志,2022,7(51):823-830.
[3] 耿倩雯,胡健强,张东伟,等.凝血酶原时间、活化部分凝血活酶时间、纤维蛋白原、凝血酶时间、心肌指标检测在冠心病诊断中的意义[J].陕西医学杂志,2022,51(10):1309-1312.
[4] Schamroth-Pravda M,Yehuda D,Schamroth-Pravda N,et al.Risk factors for superficial thrombophlebitis:A retrospective case control study[J].Isr Med Assoc J,2022,25(12):847-850.
[5] Xu Y,Siegal DM,Anand SS.Ethnoracial variations in venous thrombosis:Implications for management,and a call to action[J].J Thromb Haemost,2021,19(1):30-40.
[6] Ten-Cate H,Hackeng TM,García De-Frutos P.Coagulation factor and protease pathways in thrombosis and cardiovascular disease[J].Thromb Haemost,2017,117(7):1265-1271.
[7] 薛 乐,闫晓琴,王秋艳.大量输血患者凝血功能和纤溶系统指标变化及临床意义[J].陕西医学杂志,2020,49(10):1343-1346.
[8] Morrow M,Lynch-Smith D.Factor V leiden:Development of VTE in surgery and trauma patients:A systematic review[J].Dimens Crit Care Nurs,2022,41(4):190-199.
[9] Méan M,Limacher A,Stalder O,et al.Do factor V leiden and prothrombin G20210A mutations predict recurrent venous thromboembolism in older patients [J].Am J Med,2017,130(10):e17-e22.
[10] Salomon O,Barel O,Eyal E,et al.c.259A>C in the fibrinogen gene of alpha chain(FGA)is a fibrinogen with thrombotic phenotype[J].Appl Clin Genet,2019,12:27-33.
[11] 王思允,汪亚琼,陈晓颖.补肾活血安胎方治疗妊娠早期绒毛膜下血肿疗效研究[J].陕西中医,2022,43(10):1369-1372.
[12] Ehsani M,Imani A,Moravveji A.Prevalence of factor V leiden,MTHFR C677T and MTHFR A1298C polymorphisms in patients with deep vein thrombosis in central iran[J].Mol Biol Rep,2018,45(4):621-624.
[13] Wang Y,Du M,Vallis J,et al.The roles of MTRR and MTHFR gene polymorphisms in colorectal cancer survival[J].Nutrients,2022,14(21):4594.
[14] Nefic H,Mackic-Djurovic M,Eminovic I.The frequency of the 677C>T and 1298A>C polymorphisms in the Methylenetetrahydrofolate Reductase(MTHFR)gene in the population[J].Med Arch,2018,72(3):164-169.
[15] Li L,Wu X,Wu W,et al.Clinical manifestation and mutation spectrum of 53 unrelated pedigrees with protein S deficiency in China[J].Thromb Haemos,2019,119(3):449-460.
[16] Wypasek E,Corral J,Alhenc-Gelas M,et al.Genetic characterization of antithrombin,protein C,and protein S deficiencies in Polish patients[J].Pol Arch Intern Med,2017,127(7-8):512-523.
[17] Dahlback B.Vitamin K-dependent protein S:Beyond the protein C pathway[J].Seminars in Thrombosis and Hemostasis,2018,44(2):176-184.
[18] Juhl D,Kuta P,Shneyder M,et al.Two novel variants in the protein S gene PROS1 are associated with protein S deficiency and thrombophilia[J].Acta Haematol,2021,144(2):222-226.
[19] Di-Minno MN,Ambrosino P,Ageno W,et al.Natural anticoagulants deficiency and the risk of venous thromboembolism:A meta-analysis of observational studies[J].Thromb Res,2015,135(5):923-932.
[20] Darlow J,Mould H.Thrombophilia testing in the era of direct oral anticoagulants[J].Clin Med(Lond),2021,21(5):e487-e491.
[21] Zhang F,Gui Y,Lu Y,et al.Novel SERPINC1 missense mutation(Cys462Tyr)causes disruption of the 279Cys-462Cys disulfide bond and leads to type Ⅰ hereditary antithrombin deficiency[J].Clin Biochem,2020,85:38-42.
[22] Zeng W,Hu B,Tang L,et al.Recurrent mutations in a SERPINC1 hotspot associate with venous thrombosis without apparent antithrombin deficiency[J].Oncotarget,2017,8(48):84417-84425.
[23] Van-Mens TE,Liang HH,Basu S,et al.Variable phenotypic penetrance of thrombosis in adult mice after tissue-selective and temporally controlled Thbd gene inactivation[J].Blood Advances,2017,1(15):1148-1158.
[24] Tang L,Wang HF,Lu X,et al.Common genetic risk factors for venous thrombosis in the Chinese population[J].Am J Hum Genet,2013,92(2):177-187.
[25] Tang L,Zeng W,Lu X,et al.Identification of APOH polymorphisms as common genetic risk factors for venous thrombosis in the Chinese population[J].J Thromb Haemost,2014,12(10):1616-1625.